Eligibility Factors in Multiple Myeloma Transplant

Source: Pharmacy Times articles Gabriel Hinojosa, PharmD, BCOP, analyzes eligibility factors and treatment shifts in multiple myeloma care, considering autologous stem cell transplant risks and evolving therapy approaches with daratumumab. Read More